Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, Co-testing, HPV Primary testing, Pap Test) by Application (Pap Test, Cervical Cancer Screening, Vaginal Cancer Screening) by End Users (Hospitals, Commercial Laboratories, Ambulatory Care Centers) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.

In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share in 2017 and the Asia Pacific is also considered as the fastest growing market in the forecasted period owing to their market demands. At the country level, U.S China and India is projected to grow strongly in the coming years increased cases of cervical cancer and the growing awareness amongst women.

Drivers:

Increasing Awareness of Cervical Cancer Screening Programs

Restraints:

Changing government regulations and norms.

Opportunities:

Government Initiatives and Funding

Challenges:

Uncertain Reimbursement Scenario

The segmentation is done on the basis of resin type, by Test type, by application, by end use, and by region. The Pap test segment is expected to account for the largest share of the HPV testing market in 2015. HPV testing segment is expected to grow at the highest CAGR of XX%.

On the basis of type of application, the global HPV testing market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected to account for the largest share of the Pap test market in 2017.

Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson and Company (U.S.) are some of the key players in the Global HPV Testing & PAP Test market.

Key Benefits for Stakeholders

HPV Testing & Pap test products Manufacturers, Distributors, and Retailers

Healthcare and R&D institutions

Research and Consulting Organization

End-use industries

Investment research firms

By Test Type

HPV Testing

Follow-up HPV Testing

Co-testing

HPV Primary testing

Pap Test

By Application

Pap Test

Cervical Cancer Screening

Vaginal Cancer Screening

By End Users

Hospitals

Commercial Laboratories

Ambulatory Care Centers

Other settings

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Arbor Vita Corporation

Femasys Inc. 

Onco Health Corporation 

Seegene, Inc. 

Becton, Dickinson and Company 

Quest Diagnostics 

Abbott Laboratories 

Hologic, Inc. 

Qiagen N.V. 

Roche Diagnostics

(A brief overview of 10 companies is also provided)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. HPV Testing & PAP Test Market, By Test Type

6.1 HPV Testing

6.2 Follow-up HPV Testing

6.3 Co-testing

6.4 HPV Primary testing

6.5 Pap Test

7. HPV Testing & PAP Test Market, By Application

7.1 Pap Test

7.2 Cervical Cancer Screening

7.3 Vaginal Cancer Screening

8. HPV Testing & Pap test Market, By End Users

8.1 Hospitals

8.2 Commercial Laboratories

8.3 Ambulatory Care Centers

8.4 Other settings

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. U.K.

       9.3.2. Germany

       9.3.3. France

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. South Korea

       9.4.2. China

       9.4.3. Japan

       9.4.4. RoAPAC

9.5. RoW

       9.5.1. Latin America

       9.5.2. Middle East and Africa

10. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

10.1 Arbor Vita Corporation

10.2 Femasys Inc. 

10.3 Onco Health Corporation 

10.4 Seegene, Inc. 

10.5 Becton, Dickinson and Company 

10.6 Quest Diagnostics 

10.7 Abbott Laboratories 

10.8 Hologic, Inc. 

10.9 Qiagen N.V. 

10.10 Roche Diagnostics 

(A brief overview of 10 companies is also provided.)

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

*The list of tables and figures will be provided in the sample report.

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports